%0 Journal Article %A Barba Reyes, Juan Manuel %T Gene regulatory networks in parkinson's disease %D 2026 %U http://hdl.handle.net/10498/40566 %X Parkinson's disease (PD) has historically been understood as a primarily neuronal disorder, but growing evidence makes clear that glial cell dysfunction plays an active role in driving neurodegeneration. This doctoral thesis presents a high-resolution transcriptomic and spatial atlas of glial cells in the human dorsal striatum, covering both caudate nucleus and putamen, with the aim of deciphering their contribution to PD pathogenesis. By combining single-nucleus RNA sequencing (snRNA-seq) with image-based spatial transcriptomics (Xenium platform), we analyzed postmortem samples from 56 donors (36 with PD and 20 neurologically healthy controls), profiling over 270,000 glial nuclei. The analysis revealed a profound pathological remodeling across all three major glial lineages. In oligodendrocytes, which represent the most abundant glial population, we identified 15 transcriptionally distinct subpopulations, among which several disease-specific states emerged (PDAO-1, PDAO-2, PDAO-3, and PDAOPCs). These disease-associated states change their homeostatic myelinating function in favor of survival under proteostatic stress, as reflected by strong upregulation of heat shock proteins. This functional deviation disrupts normal maturation trajectories, collapses the adhesion signaling required for axonal contact, and correlates directly with alterations in myelination, as demonstrated by reduced MBP immunoreactivity in striatal tissue. In astrocytes and microglia, the results are equally striking. The homeostatic astrocyte population (A0) declines in favor of two divergent reactive phenotypes in PD patients: AR1, defined by proteostatic stress adaptation, and AR2, characterized by overt neuroinflammation and metabolic stress. In parallel, microglia shift away from their homeostatic surveillance state (MH) toward disease-associated phenotypes including phagocytically and metabolically exhausted DAM cells, markedly pro-inflammatory M1 states, and a heat-shock-protein-enriched stress phenotype (MH-HSP). Perhaps the most conceptually significant finding concerns how this cellular remodeling unfolds across disease progression. Stratification by Braak Lewy body stage revealed that PD does not follow a single glial pathological trajectory. Instead, the data point to the existence of two mutually exclusive reactive programs across patients: an inflammatory/reactive program, dominated by AR2 astrocytes and M1 microglia, and a proteostatic stress program defined by the unfolded protein response (UPR), with predominance of AR1 astrocytes, MH-HSP microglia, and PDAO oligodendrocytes. Different subjects appear to engage preferentially one or the other of these programs, which challenges the traditional view of PD as a disease with a single, uniform glial progression. Taken together, this thesis demonstrates that PD triggers a coordinated dysfunction of the entire glial network in the dorsal striatum, altering cells that should be protective into amplifiers of tissue damage. The identification of two clearly distinct glial profiles (reactive and UPR programs) reframes our understanding of neurodegeneration at the cellular level. Beyond that, it lays the conceptual groundwork for future patient stratification based on biofluid biomarkers, opening a realistic path toward personalized therapeutic strategies that could modify disease course by targeting the specific glial dysfunctions driving each patient's pathology. %~ Universidad de Cádiz